SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-22-000034
Filing Date
2022-03-17
Accepted
2022-03-17 16:51:07
Documents
5
Effectiveness Date
2022-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_2022planincrease.htm S-8 75832
2 EX-FILING FEES alpn-ex107_20220317.htm EX-FILING FEES 14253
3 EX-5.1 alpn-ex51_20220317.htm EX-5.1 7450
4 EX-23.1 alpn-ex231_20220317.htm EX-23.1 2379
5 image_0a.jpg GRAPHIC 74541
  Complete submission text file 0001626199-22-000034.txt   203747
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263652 | Film No.: 22749537
SIC: 2834 Pharmaceutical Preparations